ClinicalTrials.Veeva

Menu

TIPE2 Associated With Kidney Transplant

H

Health Science Center of Xi'an Jiaotong University

Status

Suspended

Conditions

Renal Transplant

Study type

Observational

Funder types

Other

Identifiers

NCT01059292
jia123456

Details and patient eligibility

About

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.

Enrollment

93 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • long-term surival(>5year),AR and CR kidney transplant patients and healty Volunteers as control

Exclusion criteria

  • without hepatitis , tumor and infections

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems